Serum concentrations of immunoglobulins and complement components in women using an intra-uterine contraceptive device (IUCD).
Immunoglobulins A, G and M and the complement components C3, C4 and CI-INH were quantified in sera from 59 women using an intra-uterine contraceptive device (IUCD). Most of the women were using a Cu IUCD, and the mean duration of use was 7.3 years. No differences in the concentrations were detected compared with control subjects. Our data, however, do not exclude a possible temporary change in the concentrations of immunoglobulins and complement components.
Sandvei
R
R
Department of Obstetrics and Gynecology, University of Bergen, Norway.
Matre
R
R
D000328:Adult; D003174:Complement C1 Inactivator Proteins / Q000032:analysis; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007435:Intrauterine Devices, Copper / Q000009:adverse effects*; D008875:Middle Aged
D003174:Complement C1 Inactivator Proteins; D003176:Complement C3; D003181:Complement C4; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D003165:Complement System Proteins